Stem Cell-based Screening

Stem Cell-Based Screening is a phenotypic screening approach that utilizes differentiated or undifferentiated stem cells as a biological system to identify compounds or genetic factors inducing specific cellular phenotypes, distinguished by its reliance on stem cell-derived models to recapitulate developmental or disease-related processes in vitro.

37

Publications

1.8K

Citations

282

Authors

106

Institutions

Publications per year

2017–2026

11

Authors

282

  1. LS
    Lorenz Studer

    Kettering University, United States

    2 publications · 311 citations

    2

    h-index

  2. HR
    Hans R. Schöler

    Max Planck Institute for Molecular Biomedicine, Germany

    2 publications · 83 citations

    2

    h-index

  3. DN
    D.R. Newall

    Newcastle University, United Kingdom

    2 publications · 52 citations

    2

    h-index

  4. KB
    K Beedles

    Research Institute of Molecular Pathology, Austria

    2 publications · 52 citations

    2

    h-index

  5. HW
    Herbert Waldmann

    Max Planck Institute of Molecular Physiology, Germany

    2 publications · 23 citations

    2

    h-index

1–5 of 282

Venues

  1. Cell stem cell

    2 publications · 129 citations

    2

    h-index

  2. Stem Cell Research

    2 publications · 64 citations

    2

    h-index

  3. PLoS ONE

    2 publications · 76 citations

    2

    h-index

  4. Toxicology in Vitro

    2 publications · 52 citations

    2

    h-index

  5. Journal of Cardiovascular Pharmacology

    1 publications · 17 citations

    1

    h-index

1–5